Mirxes Holding Company Limited

HK$12.41As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2629Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (81.74%)
Mkt cap HK$3.663B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
22.14%
502.57%
Hold 10|5|1|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.13
0.12
0.12
9.32%
(0.23%)
(8.55%)
(2.24%)
Revenue$M
284.5
286.8
284.5
299.6
5.12%
7.12%
4.26%
8.16%
Peers (US$467.3M)
Cap (US$)
PE
465.7M
—
Capital
TTM
5Y
10Y
Leveragex
0.104
0.175
0.136
EBIT/Intx
2.178
0.218
0.232
Own earn%
66.36
55.33
62.38
Sh yield%
31.74
48.96
47.25
Owners
Insiders/Inst%
1.91
60.70
Short interest%
2.66
SBC / revenue%
1.24
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
18–24
$1 testx
−0.1
Incr. ROIC%
10